Benitec Biopharma Inc.
(BNTC)
undefined
undefined%
At close: undefined
11.77
-0.84%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | 216.00K | 75.00K | 73.00K | 59.00K | 97.00K | 11.32M | 455.45K | 450.31K | 346.51K | 829.13K | 1.02M | 545.73K |
Cost of Revenue | 108.00K | 381.00K | 9.00K | 123.00K | 268.06K | 426.51K | 331.30K | 209.02K | 103.80K | 30.68K | 37.66K | 176.13K |
Gross Profit | 108.00K | -306.00K | 64.00K | -64.00K | -171.06K | 10.89M | 124.15K | 241.29K | 242.70K | 798.45K | 980.10K | 369.60K |
Operating Income | -22.49M | -19.08M | -17.85M | -13.60M | -8.28M | 2.00M | -8.55M | -15.92M | -24.96M | -13.33M | -14.40M | -8.16M |
Interest Income | - | 49.55K | 46.35K | - | 62.00K | 119.06K | - | - | - | - | - | - |
Pretax Income | -22.37M | -19.56M | -18.21M | -13.88M | -8.27M | 2.87M | -8.55M | -4.37M | -18.50M | -8.83M | -10.84M | -6.84M |
Net Income | -21.75M | -19.56M | -18.56M | -13.78M | -8.30M | 2.87M | -8.55M | -4.37M | -18.50M | -8.83M | -10.84M | -6.42M |
Selling & General & Admin | 6.99M | 6.38M | 6.65M | 6.51M | 5.57M | 6.66M | 6.41M | 6.99M | 8.96M | 6.17M | 7.67M | 4.39M |
Research & Development | 15.61M | 12.77M | 11.27M | 7.02M | 3.00M | 2.17M | 5.06M | 5.32M | 9.92M | 4.78M | 5.86M | 3.43M |
Other Expenses | -216.00K | -30.00K | -79.00K | 37.00K | -5.00K | 154.77K | 734.59 | -7.91M | -2.68M | -2.14M | -2.18M | -708.18K |
Operating Expenses | 22.38M | 19.16M | 17.92M | 13.53M | 8.56M | 8.99M | 8.68M | 4.40M | 16.20M | 8.80M | 11.35M | 7.11M |
Interest Expense | 904.00K | 33.00K | 32.00K | 6.00K | - | - | - | - | - | - | - | - |
Selling & Marketing Expenses | 277.00K | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 22.49M | 19.16M | 17.93M | 13.65M | 8.38M | 9.41M | 9.01M | 4.61M | 16.31M | 8.84M | 11.38M | 7.28M |
Income Tax | -619.00K | 3.00K | 354.00K | -101.00K | 27.00K | -864.22K | 1.47K | 209.79K | -9.00M | 821.46K | -4.03M | -414.32K |
Shares Outstanding (Basic) | 4.06M | 1.39M | 480.69K | 252.67K | 60.07K | 50.40K | 41.27K | 34.40K | 27.90K | 22.65K | 17.73K | 4.43K |
Shares Outstanding (Diluted) | 4.06M | 1.39M | 480.69K | 252.67K | 60.07K | 50.40K | 41.27K | 34.40K | 27.90K | 22.65K | 17.73K | 4.43K |
EPS (Basic) | -5.36 | -14.12 | -38.62 | -54.54 | -138.19 | 56.89 | -207.21 | -127.11 | -663.12 | -389.77 | -611.08 | -1.45K |
EPS (Diluted) | -5.36 | -14.12 | -38.62 | -54.54 | -138.19 | 56.89 | -207.21 | -127.11 | -663.12 | -389.77 | -611.08 | -1.45K |
EBITDA | -22.49M | -18.70M | -17.85M | -13.60M | -7.91M | 2.74M | -8.59M | -4.19M | -13.42M | -7.93M | -9.90M | -6.64M |
Depreciation & Amortization | - | 381.00K | 392.00K | 424.00K | 374.00K | 154.77K | 142.51K | 166.75K | 11.54M | 74.40K | 4.50M | 1.52M |